Boehringer’s Jardiance now gets CDSCO nod for chronic kidney disease
Boehringer Ingelheim’s (BI) on Wednesday mentioned its diabetes drug Jardiance (empagliflozin) 10mg dosage kind has now been accepted by the ...
Boehringer Ingelheim’s (BI) on Wednesday mentioned its diabetes drug Jardiance (empagliflozin) 10mg dosage kind has now been accepted by the ...
German drug maker Boehringer Ingelheim (BI) on Thursday mentioned it has obtained approval from the Central Medicine Normal Management Organisation ...
Copyright © 2022 Asia Today.